File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis

TitleEffect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis
Authors
Issue Date1991
PublisherS Karger AG. The Journal's web site is located at http://www.karger.com/NEF
Citation
Nephron, 1991, v. 59 n. 1, p. 100-103 How to Cite?
AbstractOral phosphatidylcholine at 900 mg/day was given to 4 patients with high lymph absorption for 8 weeks. Fluid and solute transfer before and after treatment were compared to 4 similar controls given placebo. None of the patients had overt ultrafiltration problems. After treatment, overnight peritoneal effluent phospholipid content did not change significantly. Ultrafiltration as well as solute and glucose transfer remained unchanged at the end of 8 weeks. A controlled trial on patients with overt ultrafiltration problems for a longer duration is required to further elucidate the role of phosphatidylcholine supplementation in patients on continuous ambulatory peritoneal dialysis.
Persistent Identifierhttp://hdl.handle.net/10722/161867
ISSN
2004 Impact Factor: 1.462
2006 SCImago Journal Rankings: 0.715
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChan, PCKen_US
dc.contributor.authorTam, SCFen_US
dc.contributor.authorRobinson, JDen_US
dc.contributor.authorYu, Len_US
dc.contributor.authorIp, MSMen_US
dc.contributor.authorChan, CYen_US
dc.contributor.authorCheng, IKPen_US
dc.date.accessioned2012-09-05T05:15:38Z-
dc.date.available2012-09-05T05:15:38Z-
dc.date.issued1991en_US
dc.identifier.citationNephron, 1991, v. 59 n. 1, p. 100-103en_US
dc.identifier.issn0028-2766en_US
dc.identifier.urihttp://hdl.handle.net/10722/161867-
dc.description.abstractOral phosphatidylcholine at 900 mg/day was given to 4 patients with high lymph absorption for 8 weeks. Fluid and solute transfer before and after treatment were compared to 4 similar controls given placebo. None of the patients had overt ultrafiltration problems. After treatment, overnight peritoneal effluent phospholipid content did not change significantly. Ultrafiltration as well as solute and glucose transfer remained unchanged at the end of 8 weeks. A controlled trial on patients with overt ultrafiltration problems for a longer duration is required to further elucidate the role of phosphatidylcholine supplementation in patients on continuous ambulatory peritoneal dialysis.en_US
dc.languageengen_US
dc.publisherS Karger AG. The Journal's web site is located at http://www.karger.com/NEFen_US
dc.relation.ispartofNephronen_US
dc.subject.meshAbsorptionen_US
dc.subject.meshAdministration, Oralen_US
dc.subject.meshAdulten_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshKidney Failure, Chronic - Drug Therapy - Physiopathology - Therapyen_US
dc.subject.meshLipids - Blooden_US
dc.subject.meshLymph - Drug Effects - Physiologyen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPeritoneal Dialysis, Continuous Ambulatory - Adverse Effectsen_US
dc.subject.meshPhosphatidylcholines - Administration & Dosage - Therapeutic Useen_US
dc.titleEffect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysisen_US
dc.typeArticleen_US
dc.identifier.emailIp, MSM:msmip@hku.hken_US
dc.identifier.authorityIp, MSM=rp00347en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1159/000186527-
dc.identifier.pmid1944720-
dc.identifier.scopuseid_2-s2.0-0025788538en_US
dc.identifier.volume59en_US
dc.identifier.issue1en_US
dc.identifier.spage100en_US
dc.identifier.epage103en_US
dc.identifier.isiWOS:A1991GB77600020-
dc.publisher.placeSwitzerlanden_US
dc.identifier.scopusauthoridChan, PCK=7403497841en_US
dc.identifier.scopusauthoridTam, SCF=7202037323en_US
dc.identifier.scopusauthoridRobinson, JD=7405867967en_US
dc.identifier.scopusauthoridYu, L=8617704200en_US
dc.identifier.scopusauthoridIp, MSM=7102423259en_US
dc.identifier.scopusauthoridChan, CY=24517697500en_US
dc.identifier.scopusauthoridCheng, IKP=7102537483en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats